医学
阿尔茨海默病
病理
死后研究
疾病
退行性疾病
尸检
中枢神经系统疾病
痴呆
脑脊液
作者
Pia Kivisäkk,Hadia Fatima,Chenyan Wu,Nikhil Padmanabhan,Daniel Romero,Taron Gorham,Molly Weik,Hiroko Dodge,Clemens R. Scherzer,Sudeshna Das,Lori B. Chibnik,Deborah L. Blacker,Teresa Gómez‐Isla,Derek H. Oakley,Matthew P. Frosch,Bradley T. Hyman,Catherine Demos,George Sigal,Jacob N. Wohlstadter,Alberto Serrano-Pozo
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2026-01-29
卷期号:106 (4): e214351-e214351
被引量:1
标识
DOI:10.1212/wnl.0000000000214351
摘要
Plasma pTau217, but not GFAP or NfL, levels accurately reflect the presence of ADNC in the brain even in individuals with an NPDx1 of a non-AD dementia. Thus, a positive plasma pTau217 test in an individual with a suspected non-AD dementia should not necessarily be considered a misdiagnosis of the presumed non-AD dementia or as a false positive, but rather as evidence of ADNC copathology.
科研通智能强力驱动
Strongly Powered by AbleSci AI